NDC 80425-0199-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0199
- Requested NDC
- 80425-0199-01
- Package NDCs from labels
- 80425-0199-2, 80425-0199-3, 80425-0199-1, 80425-0199-4, 80425-0199-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0199-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 | |
| 80425-0199-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 5 | |
| 80425-0199-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 5 | |
| 80425-0199-4 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0199 | GABAPENTIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250101_ec1c621b-db2a-1567-e053-2995a90a8695.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0199-1 | EA - Each | 80425-0199 | d68dc437-0849-41c2-b17b-257d12f6b61c | 1 | 2023-06-06 |
| 80425-0199-2 | EA - Each | 80425-0199 | 72852c7a-f605-4712-bd72-41cd7fab8078 | 1 | 2023-06-06 |
| 80425-0199-3 | EA - Each | 80425-0199 | d088f4ae-c84a-47de-954a-d5659921b2bf | 1 | 2023-06-06 |
| 80425-0199-4 | EA - Each | 80425-0199 | 23d7cfee-4b7b-41a1-a066-247e8cdd763e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | c9944562-563a-423d-972c-f0313375d234 | 2024-04-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Medsource Pharmaceuticals | 12f0c2ee-9a44-9778-e063-6294a90a3b58 | 2024-03-05 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 1749d731-bc8c-4374-b2a9-7c809c457f56 | 2024-03-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Medsource Pharmaceuticals | 1278512b-1493-db65-e063-6394a90ab161 | 2024-02-28 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 7a2aa696-7dac-4d03-916a-374b61a255b5 | 2024-02-16 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 79cd9dea-e7d0-44db-afba-964cb99f32b6 | 2024-01-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | f9bf87e4-5499-4dd7-a0c1-16025a718d14 | 2024-01-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | f38098ec-dd1a-405a-bbfb-bad62e4e7fa5 | 2024-01-04 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 56967a93-b3c0-4043-9241-585fc64e2624 | 2023-12-20 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | e286ed87-5fbc-4ff2-a05e-1f7fa658bbfc | 2023-12-20 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 0eb27e64-1488-4083-82c7-cebb8c0605de | 2023-12-20 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | ecb798a0-377d-4712-bb82-ec9d7116962f | 2023-12-09 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 40bb60c0-a2f3-4e7f-b13c-028c906c4852 | 2023-11-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9c96b488-19bd-431e-af9a-b313ffd9eaae | 2023-10-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 5fb79774-c2d4-47ba-9a16-eb367d0fdcff | 2023-09-30 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | af62bb7e-162e-4e2a-8eb0-d50f66678707 | 2023-09-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 77d1d90d-e124-4db7-b811-754d535e579c | 2023-09-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 22f2294f-352a-4515-87c8-a6ae46e61322 | 2023-05-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals Inc. | 323dad14-ded9-4432-a265-c957e46cc6db | 2023-03-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 35004f84-90ae-45f0-a2ba-653dec507229 | 2023-03-01 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.